U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Books

Items: 14

1.
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
William D Tap, Zsuzsanna Papai, Brian A Van Tine, Steven Attia, Kristen N Ganjoo, Robin L Jones, Scott Schuetze, Damon Reed, Sant P Chawla, Richard F Riedel, Anders Krarup-Hansen, Maud Toulmonde, Isabelle Ray-Coquard, Peter Hohenberger, Giovanni Grignani, Lee D Cranmer, Scott Okuno, Mark Agulnik, William Read, Christopher W Ryan, Thierry Alcindor, Xavier F Garcia del Muro, G Thomas Budd, Hussein Tawbi, Tillman Pearce, Stew Kroll, Denise K Reinke, Patrick Schöffski
Lancet Oncol. Author manuscript; available in PMC 2020 Dec 29.
Published in final edited form as: Lancet Oncol. 2017 Aug; 18(8): 1089–1103. Published online 2017 Jun 23. doi: 10.1016/S1470-2045(17)30381-9
PMCID:
PMC7771354
AbstractArticlePDF–1.0M
2.
Olaratumab and doxorubicin versus doxorubicin alone in soft tissue sarcoma
William D. Tap, Robin L. Jones, Brian A. Van Tine, Bartosz Chmielowski, Anthony D. Elias, Douglas Adkins, Mark Agulnik, Matthew M. Cooney, Michael B. Livingston, Gregory Pennock, Meera R. Hameed, Gaurav D. Shah, Amy Qin, Ashwin Shahir, Damien M. Cronier, Robert Ilaria, Jr, Ilaria Conti, Jan Cosaert, Gary K. Schwartz
Lancet. Author manuscript; available in PMC 2017 Oct 19.
Published in final edited form as: Lancet. 2016 Jul 30; 388(10043): 488–497. Published online 2016 Jun 9. doi: 10.1016/S0140-6736(16)30587-6
PMCID:
PMC5647653
AbstractArticlePDF–709K
3.
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Beatrice Seddon, Sandra J Strauss, Jeremy Whelan, Michael Leahy, Penella J Woll, Fiona Cowie, Christian Rothermundt, Zoe Wood, Charlotte Benson, Nasim Ali, Maria Marples, Gareth J Veal, David Jamieson, Katja Küver, Roberto Tirabosco, Sharon Forsyth, Stephen Nash, Hakim-Moulay Dehbi, Sandy Beare
Lancet Oncol. 2017 Oct; 18(10): 1397–1410. doi: 10.1016/S1470-2045(17)30622-8
PMCID:
PMC5622179
AbstractArticlePDF–510K
4.
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
B. J. Monk, M. F. Brady, C. Aghajanian, H. A. Lankes, T. Rizack, J. Leach, J. M. Fowler, R. Higgins, P. Hanjani, M. Morgan, R. Edwards, W. Bradley, T. Kolevska, P. Foukas, E. M. Swisher, K. S. Anderson, R. Gottardo, J. K. Bryan, M. Newkirk, K. L. Manjarrez, R. S. Mannel, R. M. Hershberg, G. Coukos
Ann Oncol. 2017 May; 28(5): 996–1004. Published online 2017 Feb 21. doi: 10.1093/annonc/mdx049
PMCID:
PMC5406764
AbstractArticlePDF–718K
5.
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study
Nadia Harbeck, Steffen Saupe, Elke Jäger, Marcus Schmidt, Rolf Kreienberg, Lothar Müller, Burkhard Joerg Otremba, Dirk Waldenmaier, Julia Dorn, Mathias Warm, Michael Scholz, Michael Untch, Maike de Wit, Jana Barinoff, Hans-Joachim Lück, Philipp Harter, Doris Augustin, Paul Harnett, Matthias W. Beckmann, Salah-Eddin Al-Batran, On behalf of the PELICAN Investigators
Breast Cancer Res Treat. 2017; 161(1): 63–72. Published online 2016 Oct 31. doi: 10.1007/s10549-016-4033-3
PMCID:
PMC5222915
AbstractArticlePDF–695K
6.
Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
Hee Chul Nam, Bohyun Jang, Myeong Jun Song
World J Gastroenterol. 2016 Oct 28; 22(40): 8853–8861. Published online 2016 Oct 28. doi: 10.3748/wjg.v22.i40.8853
PMCID:
PMC5083790
AbstractArticlePDF–2.3M
7.
Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study
W Janni, N Harbeck, B Rack, D Augustin, J Jueckstock, A Wischnik, K Annecke, C Scholz, J Huober, T Zwingers, T W P Friedl, M Kiechle
Br J Cancer. 2016 Apr 12; 114(8): 863–871. Published online 2016 Mar 31. doi: 10.1038/bjc.2016.82
PMCID:
PMC4984804
AbstractArticlePDF–674K
8.
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
Karen T. Brown, Richard K. Do, Mithat Gonen, Anne M. Covey, George I. Getrajdman, Constantinos T. Sofocleous, William R. Jarnagin, Michael I. D’Angelica, Peter J. Allen, Joseph P. Erinjeri, Lynn A. Brody, Gerald P. O’Neill, Kristian N. Johnson, Alessandra R. Garcia, Christopher Beattie, Binsheng Zhao, Stephen B. Solomon, Lawrence H. Schwartz, Ronald DeMatteo, Ghassan K. Abou-Alfa
J Clin Oncol. 2016 Jun 10; 34(17): 2046–2053. Published online 2016 Feb 1. doi: 10.1200/JCO.2015.64.0821
PMCID:
PMC4966514
AbstractArticlePDF–1019K
9.
Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer
Seth P. Lerner, Dean F. Bajorin, Colin P. Dinney, Jason A. Efstathiou, Susan Groshen, Noah M. Hahn, Donna Hansel, David Kwiatkowski, Michael O’Donnell, Jonathan Rosenberg, Robert Svatek, Jeffrey S. Abrams, Hikmat Al-Ahmadie, Andrea B. Apolo, Joaquim Bellmunt, Margaret Callahan, Eugene K. Cha, Charles Drake, Jonathan Jarow, Ashish Kamat, William Kim, Margaret Knowles, Bhupinder Mann, Luigi Marchionni, David McConkey, Lisa McShane, Nilsa Ramirez, Andrew Sharabi, Arlene H. Sharpe, David Solit, Catherine M. Tangen, Abdul Tawab Amiri, Eliezer Van Allen, Pamela J. West, J. A. Witjes, Diane Zipursky Quale
Bl Cancer. 2016; 2(2): 165–202. Published online 2016 Apr 27. doi: 10.3233/BLC-160053
PMCID:
PMC4927845
AbstractArticlePDF–1.9M
10.
Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study
N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network
Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.
Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006
PMCID:
PMC4446235
AbstractArticlePDF–546K
11.
Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladder
Michael S. Cookson, Sam S. Chang, Christine Lihou, Thomas Li, Samira Q. Harper, Zhihui Lang, Ronald F. Tutrone
Ther Adv Urol. 2014 Oct; 6(5): 181–191. doi: 10.1177/1756287214541798
PMCID:
PMC4144261
AbstractArticlePDF–630K
12.
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Adrian Reuben, David G. Koch, William M. Lee, the Acute Liver Failure Study Group
Hepatology. Author manuscript; available in PMC 2014 Apr 20.
Published in final edited form as: Hepatology. 2010 Dec; 52(6): 2065–2076. Published online 2010 Oct 14. doi: 10.1002/hep.23937
PMCID:
PMC3992250
AbstractArticlePDF–328K
13.
An Evaluation of Hepatotoxicity in Breast Cancer Patients Receiving Injection Doxorubicin
G Damodar, T Smitha, S Gopinath, S Vijayakumar, YA Rao
Ann Med Health Sci Res. 2014 Jan-Feb; 4(1): 74–79. doi: 10.4103/2141-9248.126619
PMCID:
PMC3952301
AbstractArticlePDF–812K
14.
Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States
Naga Chalasani, Robert J. Fontana, Herbert L. Bonkovsky, Paul B. Watkins, Timothy Davern, Jose Serrano, Hongqiu Yang, James Rochon, for the Drug Induced Liver Injury Network (DILIN)
Gastroenterology. Author manuscript; available in PMC 2013 May 15.
Published in final edited form as: Gastroenterology. 2008 Dec; 135(6): 1924–1934.e4. Published online 2008 Sep 17. doi: 10.1053/j.gastro.2008.09.011
PMCID:
PMC3654244
AbstractArticlePDF–96K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center